PLAA Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP1466b
Background:
PLAA stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. It plays an important role in the regulation of specific inflammatory processes connected to such diseases as inflammatory bowel disease, pancreatitis, rheumatoid arthritis, and cutaneous malignant melanoma.
Other Names:
Phospholipase A-2-activating protein, PLA2P, PLAP, PLAA, PLAP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1466b was selected from the C-term region of human PLAA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PLAA
Gene ID: 9373
Primary Accession: Q9Y263
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PLAA stimulates human neutrophil aggregation and release of lysosomal enzymes, superoxide, and eicosanoids. It plays an important role in the regulation of specific inflammatory processes connected to such diseases as inflammatory bowel disease, pancreatitis, rheumatoid arthritis, and cutaneous malignant melanoma.
Other Names:
Phospholipase A-2-activating protein, PLA2P, PLAP, PLAA, PLAP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1466b was selected from the C-term region of human PLAA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PLAA
Gene ID: 9373
Primary Accession: Q9Y263
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review